To test these new stents, we will run 'First-in-Human' trials to assess safety, performance, and patient acceptability, clinical trials

Two single-arm, multicentre unblinded first-in-human trials, including two phases and a qualitative substudy investigating a novel ureteric stent in kidney stone patients and oncology patients to determine the reduction of encrustation, biofilm deposition and complications compared to a conventional JJ stent (CASSETTE)

This study is testing a new type of tube, called a ureteric stent, for people with kidney stones or cancer. It aims to see if the new stent is safer and works better than standard stents by preventing blockages and reducing problems.